Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the unaudited ....
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Kidney and Super Speciality Limited has informed BSE that its Board of Directors will meet on Friday, February 13, 2026. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The company has also confirmed that the trading window for designated persons remains closed since January 1, 2026, and will reopen 48 hours after the results are made public, in line with SEBI insider trading rules. This is a routine compliance filing under SEBI Listing Regulations, with no actual financial numbers disclosed at this stage.
Investors should mark February 13, 2026 as the results date — the Q3 FY26 earnings print will be the next key catalyst for the stock. The closed trading window signals that insider activity is restricted until results are out, so any price movement ahead of the announcement should be viewed with caution.